Definium Therapeutics (DFTX) Metrics: History & Chart

Definium Therapeutics, Inc.(DFTX)

Biotechnology · New York, NY

$34.57-1.66 (-4.57%)

Delayed quote: Oct 6, 2026, 10:45 AM EDT

About Definium Therapeutics, Inc.

Definium Therapeutics, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to developing innovative therapeutic solutions for various brain health and neurological disorders. Its pipeline features key experimental drug candidates like MM120, which is currently undergoing Phase 3 clinical trials for generalized anxiety disorder (GAD) and attention deficit hyperactivity disorder (ADHD). Another significant compound, MM402 – an R-enantiomer of 3,4-methylenedioxymethamphetamine – is in Phase 1 trials, targeting the fundamental symptoms of autism spectrum disorder. The company maintains its headquarters in New York, New York.

New York, NY

106 employees

definiumtx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Robert Barrow

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-5.68%
30D Total Return	-4.88%
YTD Total Return	+170.58%
1Y Total Return	+188.46%
3Y Total Return	+1076.27%
5Y Total Return	+7.36%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+170.58%
2025	+92.39%
2024	+90.16%
2023	+66.36%
2022	-89.37%
2021	-54.75%
2020

CAGR TTM	+187.00%
CAGR 3Y	+127.38%
CAGR 5Y	+1.43%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

DFTX Valuation Metrics

DFTX Stock Price Metrics

DFTX Dividend Metrics

DFTX Growth Rate Metrics

DFTX Discounted Cash Flow Metrics

DFTX Returns By Period

DFTX Yearly Returns

DFTX Average Annual Returns By Period (CAGR)

DFTX Revenue Metrics

DFTX PE Ratio Metrics

DFTX PS Ratio Metrics

DFTX PB Ratio Metrics

DFTX Price to Free Cash Flow Ratio Metrics

DFTX Debt to Equity Ratio Metrics

DFTX PEG Ratio Metrics

DFTX FCF Yield

DFTX Earnings Yield

DFTX EBITDA Yield

DFTX OCF Yield

DFTX EV/EBIT Ratio Metrics

DFTX EV/EBITDA Ratio Metrics

DFTX EV/Assets Ratio Metrics

DFTX EV/Sales Ratio Metrics

DFTX Current Ratio Metrics

DFTX Quick Ratio Metrics

DFTX ROIC Metrics

DFTX Return on Assets Metrics

DFTX Return on Equity Metrics

DFTX Net Profit Margin Metrics

DFTX Gross Profit Margin Metrics

DFTX Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	4.37
PB Ratio Avg TTM	7.34
PB Ratio Avg 3Y	3.71
Current VS TTM Avg	-40.46%
Current VS 3Y Avg	+17.72%
Current VS 5Y Avg	+48.06%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.04
Debt/Equity Ratio Avg TTM	0.11
Debt/Equity Ratio Avg 3Y	0.09
Current VS TTM Avg	-65.25%
Current VS 3Y Avg	-55.25%
Current VS 5Y Avg	-25.57%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	3.05
Ev/Assets Ratio Avg TTM	4.46
Ev/Assets Ratio Avg 3Y	2.27
Current VS TTM Avg	-31.62%
Current VS 3Y Avg	+34.22%
Current VS 5Y Avg	+47.33%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	6.95
Current Ratio Avg TTM	5.24
Current Ratio Avg 3Y	5.39
Current VS TTM Avg	+32.54%
Current VS 3Y Avg	+28.92%
Current VS 5Y Avg	-2.99%

Quick Ratio	6.95
Quick Ratio Avg TTM	5.24
Quick Ratio Avg 3Y	5.39
Current VS TTM Avg	+32.54%
Current VS 3Y Avg	+28.92%
Current VS 5Y Avg	-2.99%

ROIC	(23.81%)
ROIC Avg 3Y	(56.39%)
ROIC Avg 5Y	(53.89%)
Current VS 3Y Avg	+57.78%
Current VS 5Y Avg	+55.82%
Current VS 10Y Avg	+51.11%

ROA	(31.79%)
ROA Avg TTM	(17.89%)
ROA Avg 3Y	(14.46%)
Current VS TTM Avg	-77.65%
Current VS 3Y Avg	-119.84%
Current VS 5Y Avg	-134.93%

ROE	(38.51%)
ROE Avg TTM	(73.90%)
ROE Avg 3Y	(67.28%)
Current VS TTM Avg	+47.89%
Current VS 3Y Avg	+42.76%
Current VS 5Y Avg	+29.76%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.20%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-100.00%
Current VS 10Y Avg	-100.00%